Valuation: Parnax Lab Limited

Market Cap 1.44B 15M 13.08M 12.35M 11.21M 21.01M 21.1M 148M 57.08M 732M 56.34M 55.09M 2.35B P/E 2025
10.7x
P/E 2026 12.5x
Enterprise Value 2.24B 23.39M 20.4M 19.26M 17.49M 32.77M 32.9M 231M 89.02M 1.14B 87.86M 85.91M 3.67B EV / Sales 2025
1.02x
EV / Sales 2026 0.92x
Free-Float
14.66%
Yield 2025 *
-
Yield 2026 -
1 day+1.21%
1 week-1.38%
Current month-3.76%
1 month+6.19%
3 months-6.53%
6 months+4.42%
Current year-3.62%
1 week 118.5
Extreme 118.5
129.15
1 month 116
Extreme 116
151.9
Current year 99.2
Extreme 99.2
182
1 year 99.2
Extreme 99.2
182
3 years 75.6
Extreme 75.6
193.5
5 years 22
Extreme 22
193.5
10 years 11.65
Extreme 11.65
193.5
Manager TitleAgeSince
Chief Executive Officer - 05/07/2024
Director of Finance/CFO 42 05/07/2024
Compliance Officer - 21/06/2021
Director TitleAgeSince
Director/Board Member 50 31/03/2015
Director/Board Member 72 28/05/2021
Director/Board Member 66 11/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.21%-1.38%-8.10%+35.90% 15M
-0.58%+0.43%+31.09%-4.81% 78.35B
-2.55%+6.99%+505.27%+47.92% 61.52B
-1.11%+5.08%-11.47%-33.91% 59.78B
+0.14%-1.20%-11.64%+24.21% 46.53B
-0.24%+1.22%+2.26%+151.03% 45.5B
-1.62%-0.76%+49.85%-14.92% 31.84B
-1.81%+3.16%+45.71%+110.57% 25.4B
+0.47%+3.26%-0.77%+142.41% 21.43B
+0.27%+1.96%+62.19%+102.81% 15.77B
Average -0.58%+1.84%+66.44%+56.12% 38.62B
Weighted average by Cap. -0.92%+2.35%+93.51%+40.27%

Financials

2025 2026
Net sales 1.88B 19.57M 17.06M 16.11M 14.63M 27.41M 27.53M 193M 74.48M 955M 73.51M 71.88M 3.07B 2.49B 25.91M 22.59M 21.33M 19.37M 36.29M 36.44M 256M 98.6M 1.26B 97.32M 95.16M 4.07B
Net income 115M 1.2M 1.05M 988K 898K 1.68M 1.69M 11.84M 4.57M 58.56M 4.51M 4.41M 188M 118M 1.23M 1.07M 1.01M 918K 1.72M 1.73M 12.1M 4.67M 59.87M 4.61M 4.51M 193M
Net Debt 690M 7.19M 6.27M 5.92M 5.37M 10.07M 10.11M 70.9M 27.36M 351M 27M 26.4M 1.13B 805M 8.39M 7.32M 6.91M 6.27M 11.76M 11.8M 82.76M 31.94M 409M 31.52M 30.82M 1.32B
Logo Parnax Lab Limited
Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.
Employees
12
Date Price Change Volume
18/09/26 ₹125.30 +1.21% 673
17/09/26 ₹123.80 +1.68% 93
16/09/26 ₹121.75 -1.81% 1,891
15/09/26 ₹124.00 -2.40% 1,486
11/09/26 ₹127.05 -3.49% 256
  1. Stock Market
  2. Stocks
  3. PARNAXLAB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!